2-(1-(4-Chlorobenzyl)-1H-indol-3-yl)-2-oxo-N-(pyridin-4-yl)acetamide, 95.0%, 100mg

trans-4-methoxytetrahydro-2H-pyran-3-amine hydrochloride, 95.0%, 250mg

H-D-Pro-Otbu, 95.0%, 1g

methyl 3-(5-methyl-1H-indol-3-yl)-3-oxopropanoate, 250mg

Ethyl 6-chloro-8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylate, 98+%, 100mg

1/? Primera placa roja de 530 nm en portaobjetos para iluminación incidente de modelos iScope para polarización.

Gelatina, cristal, pura, 160 bloom, 100 g, envase de plástico.

1-Benzhydryl-3-methylazetidin-3-ol, 95.0%, 1g

2-(4-Chlorophenyl)-2-(o-tolylamino)acetic acid, 98%, 250mg

4-(5,5-Dimethyl-1,3,2-dioxaborinan-2-yl)benzaldehyde, 95.0%, 10g

4-Fluoro-3-(methylsulfanyl)benzoic acid, 95+%, 1g

7-(tert-Butyl) 2-methyl 3-bromo-7-azabicyclo[2.2.1]hepta-2,5-diene-2,7-dicarboxylate, 97%, 250mg

(4,4'-Di-tert-butyl-2,2'-bipyridine-kappa~2~N~1~,N~1'~)[bis[5-fluoro-2-(5-methyl-2-pyridinyl-kappaN)phenyl-kappaC~1~]]iridium Hexafluorophosphate>90.0%(HPLC)1g